Browsing eNauka

Browsing by Project Merck KGaA, Darmstadt, Germany

Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)TypeМp-cat.
2023Avelumab in Combination With Cetuximab and Chemotherapy as First-Line Treatment for Patients With Advanced Squamous NSCLCAndric, Zoran G  ; ...; Stojanovic, Goran; Petrovic, Marina D  ; ...; (broj, koautora 21)Naučni članak
21M21 - Vodeći međunarodni časopis kategorije M21
2024Avelumab Versus Platinum-Based Doublet Chemotherapy as First-Line Treatment for Patients With High-Expression Programmed Death-Ligand 1-Positive Metastatic NSCLC: Primary Analysis From the Phase 3 JAVELIN Lung 100 TrialReck, Martin; ...; Andric, Zoran G  ; ...; (broj, koautora 18)Naučni članak
21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+
2014Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trialStupp, Roger; ...; Grujicic, Danica M; ...; (broj, koautora 37)Naučni članak
21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+
2012Efficacy and safety of subcutaneous interferon beta-1a in relapsing-remitting multiple sclerosis: Further outcomes from the IMPROVE studyDe, Stefano Nicola; Sormani, Maria Pia; Stubinski, Bettina; Blevins, Gregg; Drulovic, Jelena S  ; Issard, Delphine; Shotekov, Penko; Gasperini, ClaudioArticle
22M22
2021First-line avelumab in combination with cetuximab and chemotherapy in patients with advanced squamous non-small cell lung cancer (NSCLC)Andric, Zoran G  ; ...; Stojanovic, Goran; Petrovic, Marina D  ; ...; (broj, koautora 20)Conference Paper
Mp. category will be shown later
2018Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancerVan, Cutsem Eric; Hidalgo, Manuel; Canon, Jean-Luc; Macarulla, Teresa; Bazin, Igor; Poddubskaya, Elena; Manojlović, Nebojša S.  ; Radenkovic, Dejan V; Verslype, Chris; Eric, Raymond;
Cubillo, Antonio; Schueler, Armin; Zhao, Charles; Hammel, Pascal;
Naučni članak
21aM21a - Vodeći međunarodni časopis kategorije M21a
2015Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE studyNabors, Louis Burt; ...; Grujicic, Danica M; ...; (broj, koautora 17)Naučni članak
21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+